You are on page 1of 51

pharma SOLUTIONS

Characterization of Newly Developed Micronized Poloxamers for Poorly Soluble Drugs


Anisul Quadir, Ph.D, MBA Releasing Technology Workshops Controlled Release Society Meeting Miami, June 19, 2005

n Actives n Excipients n Contract Manufacturing n Value Added

Helping make Pharmaceuticals betterTM

Poloxamers Chemical Nature

Helping make Pharmaceuticals betterTM

Poloxamers are block-copolymers consisting of Polyoxyethylene-(POE-) and Polyoxypropylene-(POP-) units Chemical composition: CH HO CH 2 CH 2 O a CH 2 CH 3 O b CH 2 CH 2 O a H

POE-unit
Pharmacopoeial name Poloxamer 188 Poloxamer 407 a = ca. 79 a = ca. 98

POP-unit

POE-unit
Trade Name

b = ca. 28 b = ca. 57

Lutrol F 68 Lutrol F 127

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol F Grades

Helping make Pharmaceuticals betterTM

Brand Name n Lutrol F68NF n Lutrol F127NF

Pharmacopeial Name n Poloxamer 188 n Poloxamer 407

Also Available
n n n

Lutrol F87NF Lutrol L44NF Lutrol F108NF

n n n

Poloxamer 237 Poloxamer 124 Poloxamer 338

Actives

Excipients

Contract Manufacturing

Value Added

Poloxamers Characteristics

Helping make Pharmaceuticals betterTM

The character of each poloxamer in terms of:


n n n

molecular weight appearance hydrophilicity / hydrophobicity solubility

is determined by the chain length of the

polyoxyethylene(EO-) units

AND
n

polyoxypropylene(PO-) units

Actives

Excipients

Contract Manufacturing

Value Added

Poloxamer Grid

Helping make Pharmaceuticals betterTM

4000

401

402

403

407

Molecular weight of PO-part

3625 3250 2750 2250 2050 1800 1450 1200 950 0

Liquid
331 333

Paste
334 335

Solid
338

272

278

221

224

225

227

228

202

205

207

181

182

183

184

185

188

122 101

123

124 105 108

10

20

30

40

50

60

70

80

Percentage EO-part (%)


n Actives n Excipients n Contract Manufacturing n Value Added

Poloxamer grades Definition of Number Code

Helping make Pharmaceuticals betterTM

Mw of PO-part EO-part (Wt.%) Poloxamer 18 8 Poloxamer 40 7 18 x 100 = 1800 40 x 100 = 4000 8 x = 7 x = 10 80 10 70

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol Grid

Helping make Pharmaceuticals betterTM

12000 11000 10000

L121

L122

P123

F127

Liquid
L101 P103

Paste
P104 P105

Solid
F108

Molecular weight

9000 8000 7000 6000 5000 4000 3000 0


L31 L61 L81

L92

F98

P84

P85

F87

F88

L72

P75

F77

L62

L63

L64

P65

F68

L42

L43

L44 L35 F38

10

20

30

40

50

60

70

80

Percentage EO-part (%)


n Actives n Excipients n Contract Manufacturing n Value Added

Lutrol F Grades Nomenclature

Helping make Pharmaceuticals betterTM

Mw Lutrol F 6 8 6 = x 1000 6000

EO-part (Wt.%) 8 x 10 = 80 7 x 10 = 70

Lutrol F 12 7

12 x 1000 = 12000

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol F Grades Molecular Weight


arbitr. units 5 4,5 4 3,5 3 2,5 2 1, 1 0,5 0 lot-No. 89-0823 lot-No. 87-0807

Helping make Pharmaceuticals betterTM

100

1.000
molecular weight

10.000

100.000

Lutrol F 68 lot-No. 89-0823 lot-No. 87-0807


n

Mw 8,600 9,000
Actives n

Mn 7,600 8,100
Excipients n

(Mw/Mn) 1.4 1.4


Contract Manufacturing n Value Added

Lutrol F127 Molecular Weight


arbitr. units 5 4,5 4 3,5 3 2,5 2 1, 5 1 0,5 0

Helping make Pharmaceuticals betterTM

100

1.000
molecular weight

10.000

100.000

Lutrol F 127 lot-No. 41-0805 lot-No. 64-0806

Mw 13,400 13,500

Mn 9300 9500

(Mw/Mn) 1.4 1.4

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol F127 Reason for Bimodal Distribution


n

Helping make Pharmaceuticals betterTM

The molecular weight distribution is dependant on side reactions, which occur during propylene oxide polymerization. During formation of POP block, a fraction of propylene oxide may be converted to allyl alcohol which will futher react with PO and EO producing a polymeric material about half the molecular weight of the main product. This segment constitute the unsaturation part of Lutrol F127 ( 0.048 meq/gm). In the USP, the average molecular weight is 9840 to 14600.

Actives

Excipients

Contract Manufacturing

Value Added

Helping make Pharmaceuticals betterTM

Formation of Unsaturation

H H H

O
KOH

H H O

H
n+1

CH 2 CHO CH 3
n

Unsat. in USP/NF for 407 = 0.048 + 0.017 mEq/g

CH 2 CHO CH 3

CH 2 CH 2 O

Actives n Excipients CONFIDENTIAL

Contract Manufacturing

Value Added

Functionality of Poloxamer 407

Helping make Pharmaceuticals betterTM

CH3 HO-(CH2-CH2-O)x-(CH2-CH-O)y-(CH2-CH2-O)x-H where x = approx. 98 and y = approx. 57 Poloxamer is terminated with hydroxyl group therefore further reactions will not occur (will not self polymerize)
n Actives n Excipients n Contract Manufacturing n Value Added

Principle of Micellization

Helping make Pharmaceuticals betterTM

surfactant m o lecule

Polar Solvent

Actives

Excipients

Contract Manufacturing

Value Added

As a Solubilizer

Helping make Pharmaceuticals betterTM

Solubilization capacity of a poloxamer is believed to be dictated by the hydrophobic portion One theory is that in water, the poloxamer molecules arrange themselves in an umbrella like configuration:

POP Group

One Poloxamer molecule

POE Group

Actives

Excipients

Contract Manufacturing

Value Added

Limiting Aggregation Concentration

Helping make Pharmaceuticals betterTM

From the available literature: Poloxamer 188 (Lutrol F 68)


Poloxamer 338 (Lutrol F 108) Poloxamer 407 (Lutrol F 127)* 6.0 4.74 2-3 micromoles/ liter micromoles/ liter micromoles/liter

* Estimated, no published literature.

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol F Grades Applications

Helping make Pharmaceuticals betterTM

Solubilizer Solubilizer

Gels Gels

Suspension Suspension Stabilizer Stabilizer

Melt //Spray Melt Spray Granulations Granulations

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol F Grades (Poloxamers)

Helping make Pharmaceuticals betterTM

Prill
n n

Microprill
n n n

Lutrol F68 Prill Lutrol F127 Prill

Lutrol 68*micro Lutrol 127* micro Particle Size Range


n n

d (0.5) = 50micron d (0.9) = 90 micron

*Development Product

Actives

Excipients

Contract Manufacturing

Value Added

Advantages of Microprilling

Helping make Pharmaceuticals betterTM

n n n n n n n

Average particle size 50 micron Stronger solubilization activities Controlled dissolution rate Reduction of die-wall friction Achievement of homogeneous blend Elimination of dose dumping Effective water soluble lubricant

Actives

Excipients

Contract Manufacturing

Value Added

Microprill Lutrol Particle Size Specification

Helping make Pharmaceuticals betterTM

Microprill meets the following specification n Max. 10% retain in 106 micron (#140 Screen) n Max. 50% retain on 53 micron (#270 Screen)
n

Using Alpine Air Jet Sieve Analysis Chemical Specification is identical to regular prill and complies with USP/NF specification

Actives

Excipients

Contract Manufacturing

Value Added

SEM

Helping make Pharmaceuticals betterTM

Lutrol F68 Prill x50 magnification

Lutrol 68 Microprill x500 magnification

Actives

Excipients

Contract Manufacturing

Value Added

Particle Size Using Malvern Mastersizer 2000

Helping make Pharmaceuticals betterTM

Lutrol F68 Prill


Particle Size Distribution
13 12 11 10 9 Volume (%) 8 7 6 5 4 3 20 2 1 0 0.1 1 10 Particle Size (m) 100 1000 10 0 3000 60 50 40 30 100 90 80 70
Volume (%)

Lutrol 68 Microprill
Particle Size Distribution
10 9.5 9 8.5 8 7.5 7 6.5 6 5.5 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 0.1 100 90 80 70 60 50 40 30 20 10 1 10 Particle Size (m) 100 1000 0 3000

F68 Prill, sifted, WPOZ-551BK4 Averaged Result, 08/06/04 11:25:51

F68 microprilled, WPNZ-664BMP Averaged Result, 08/06/04 11:33:33

Actives

Excipients

Contract Manufacturing

Value Added

Surface Area

Helping make Pharmaceuticals betterTM

Sample

BET Surface (m2/g)

Lutrol F68 Lot # 55-0003 Lutrol 68 Microprill Lot # WPNZ-664BMP

Not Possible

0.18

Actives

Excipients

Contract Manufacturing

Value Added

Bulk / Tapped Density

Helping make Pharmaceuticals betterTM

Material Lutrol F68 Prill Lot # WPDX-577B Lutrol 68 Microprill Lot # WPNZ-664BMP

Bulk Density (g/cm3) 0.56

Tapped Density (g/cm3) 0.60

True Density (g/cm3) 0.99

0.52

0.78

1.10

Actives

Excipients

Contract Manufacturing

Value Added

Melt Viscosity

Helping make Pharmaceuticals betterTM

Viscosity (cps) Initial Stabilized

F68 Prill 807 783

68 Microprill 730 720

Equipment :

Brookfield RVT-DVII with Thermoseal & Temperature Controller Temperature Set and Maintained at 80C, Spindle #27

Actives

Excipients

Contract Manufacturing

Value Added

Molecular Weight Distribution (GPC)


-

Helping make Pharmaceuticals betterTM

Sample Name

Mn

Mw

MP

Polydispersity

% Area

Area

Retention Time

Project #

Lutrol F68 Microprill WPNZ-664BMP


(microprill) Date Acquired 10/18/04 9:05:37 AM

8611

9332

9956

1.083755

100.0

2861502

18.411

2S011

Lutrol F68 Prill WPOZ-551BK4


(normal prill) Date Acquired 10/18/04 10:45:31 AM

8809

9656

10288

1.096190

100.0

3711903

18.356

2S011

15.00

16.00

17.00

18.00

19.00

20.00

21.00

22.00 23.00 Minutes

24.00

25.00

26.00

27.00

28.00

29.00

30.00

Actives

Excipients

Contract Manufacturing

Value Added

Differential Scanning Calorimetric Data

Helping make Pharmaceuticals betterTM

Material Lutrol F68 Prill Lutrol 68 Microprill

To 48.9 50.1

Tp 51.6 52.4

H 121.7 121.7

To = Extrapoloated onset of melting endotherm in C Tp = Peak of melting endotherm in C H = Enthalpy of melting endotherm in joules/gram

Actives

Excipients

Contract Manufacturing

Value Added

DSC

Helping make Pharmaceuticals betterTM

Lutrol F68 Prill


Run : 2 2nd heat

DSC

Heat Flow (W/g)

50.09C 134.3J/g

-2

53.56C

-4

-6 -60
Exo Up

Lutrol 68 Microprill
-40 -20 0 20 40 60 80 100
Universal V3.8B TA Instruments

Temperature (C)

DSC
2

Heat Flow (W/g)

2nd heat

2C/min

49.64C 119.8J/g

-1
52.32C

Exo Up

-2 0

10

20

30

40

Temperature (C)

50

60

70

80

90

100

Actives

Excipients

Contract Manufacturing

Value Added

X-Ray Diffraction

Helping make Pharmaceuticals betterTM

14000

13000

12000

11000

n Lutrol F68 Prill n Lutrol 68 Microprill

10000

9000

Lin 8000 (Co unt 7000 s)


6000

5000

4000

3000

2000

1000

0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40

2-Theta - Scale -2 - - - -.

Actives

Excipients

Contract Manufacturing

Value Added

pharma SOLUTIONS

Case Study Effects of micronized poloxamers on poorly water soluble drugs

n Actives n Excipients n Contract Manufacturing n Value Added

Helping make Pharmaceuticals betterTM

Formulations

Helping make Pharmaceuticals betterTM

Material
Ibuprofen Carbamazepine Ltrol micro Di-calcium Phosphate Calcium Carbonate 90A Kollidon CL Aerosil 200 Magnesium Stearate

Formulation A (%) 5.0 5.0, 25.0, 50.0 79.0, 69.0, 59.0, 34.0 10.0 0.5 0.5

Formulation B (%) 5.0 25.0, 50.0 59.0, 34.0 10.0 0.5 0.5

Actives

Excipients

Contract Manufacturing

Value Added

Ibuprofen Capsule Data

Helping make Pharmaceuticals betterTM

Capsules containing Ibuprofen and Lutrol 127 Micro


90 80 70 60 50 40 30 20 1:10 Ratio 10 0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 Control 1:1 Ratio 1:5 Ratio

% Drug Release

Time (Hrs)

Dissolution Media pH 4.5 buffer

HPLC Column 5m C18 150mm x 39mm


n Actives n Excipients n

Mobile Phase: H20:Acetonitrile (40:60)


Contract Manufacturing n Value Added

Ibuprofen Tablet Data

Helping make Pharmaceuticals betterTM

Tablets containing Ibuprofen and Lutrol 127 Micro


120

100

% Drug Release

80

60

40

1:1 Ratio 1:5 Ratio

20

1:10 Ratio Control

0 0 1 2 3 4 5

Time (hrs)

Dissolution Media pH 4.5 buffer

HPLC Column 5m C18 150mm x 39mm


n Actives n Excipients n

Mobile Phase: H20:Acetonitrile (40:60)


Contract Manufacturing n Value Added

Ibuprofen and Lutrol F127 Prill vs. Micro grades (1:10)

Helping make Pharmaceuticals betterTM

Ibuprofen tablets containing Lutrol 127 Prill and Micro grades


120

100

% Drug Release

80

60

40

Lutrol 127 micro


20

Lutrol F127 Prill

0 0 1 2 3 4 5

Time (hrs)

Dissolution Media pH 4.5 buffer

HPLC Column 5m C18 150mm x 39mm


n Actives n Excipients n

Mobile Phase: H20:Acetonitrile (40:60)


Contract Manufacturing n Value Added

Conclusion For Ibuprofen

Helping make Pharmaceuticals betterTM

The addition of Lutrol 127 micro improved the dissolution of Ibuprofen

Tablets showed a greater improvement in dissolution compared to capsules

The thermoreversible gelling effect, along with the smaller particle size of Lutrol 127 micro gave a controlled release profile

Actives

Excipients

Contract Manufacturing

Value Added

Carbamazepine Formulations Process

Helping make Pharmaceuticals betterTM

Dissolution studies with tablets via direct compression and solid dispersion were evaluated Regular prill used for Solid dispersion and Microprill for Direct Compression Tablets compressed using 9.5mm round flat face bevel edge tooling Target weight 400mg, target hardness 4-5Kp Using Carbamazepine as a model drug, due to its limited solubility in water dissolution studies were carried out using a co-solvent of water and ethanol (70:30)

Actives

Excipients

Contract Manufacturing

Value Added

Carbamazepine and Lutrol 127 1:5 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 127 micro 1:5 Ratio


90 80 70

% Drug Release

60 50 40 30 20 10

Direct Compression Solid Dispersion Control

0 0 1 2 3 4 5

Time (hrs)

Dissolution Media 70:30 Ethanol:Water

HPLC Column 5m CN 250mm x 4.6mm


n Actives n Excipients n

Mobile Phase: H20:MeOH:THF (85:12:3)


Contract Manufacturing n Value Added

Carbamazepine and Lutrol 127 1:10 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 127 micro 1:10 Ratio


90 80 70

% Drug Release

60 50 40 30 20 10 0 0 1 2 3 4 5

Solid Dispersion Direct Compression Control

Time (Hrs)

Dissolution Media 70:30 Ethanol:Water

HPLC Column 5m CN 250mm x 4.6mm


n Actives n Excipients n

Mobile Phase: H20:MeOH:THF (85:12:3)


Contract Manufacturing n Value Added

Carbamazepine and Lutrol 68 1:5 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 68 micro 1:5 Ratio


90 80 70

% Drug Release

60 50 40 30 20 10 0 0 1 2 3 4 5

Solid Dispersion Direct Compression Control

Time (Hrs)
Dissolution Media 70:30 Ethanol:Water HPLC Column 5m CN 250mm x 4.6mm
n Actives n Excipients n

Mobile Phase: H20:MeOH:THF (85:12:3)


Contract Manufacturing n Value Added

Carbamazepine and Lutrol 68 1:10 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 68 micro 1:10 Ratio


120

100

% Drug Release

80

60

40

Solid Dispersion Direct Compression

20

Control
0 0 1 2 3 4 5

Time (hrs)

Dissolution Media 70:30 Ethanol:Water

HPLC Column 5m CN 250mm x 4.6mm


n Actives n Excipients n

Mobile Phase: H20:MeOH:THF (85:12:3)


Contract Manufacturing n Value Added

Conclusions For Carbamazepine

Helping make Pharmaceuticals betterTM

Both Lutrol 68 micro and Lutrol 127 micro improved the dissolution of Carbamazepine

Solid dispersion techniques appeared to provide incomplete release of Carbamazepine

Actives

Excipients

Contract Manufacturing

Value Added

pharma SOLUTIONS

Case Study 2 Comparing different granulation techniques

n Actives n Excipients n Contract Manufacturing n Value Added

Helping make Pharmaceuticals betterTM

Formulation and Process

Helping make Pharmaceuticals betterTM

Made Carbamazepine tablets using different granulation techniques: n Direct Compression n Wet Granulation n Melt Granulation Two ratios evaluated: 1:3 and 1:5 (Drug: Poloxamer) Microprill was used only in Direct Compression Tablets compressed at 400mg, target hardness 5-7Kp

n n

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol 68 micro 1:3 Ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol F 68 1:3 Ratio


120

100

% Drug Release

80

60

Direct Compression
40

Melt Granulation
20

Wet Granulation Control

0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5

Time (Mins)
n Actives n Excipients n Contract Manufacturing n Value Added

Lutrol 68 micro 1:5 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 68 1:5 Ratio


100 90 80 70

% Drug Release

60 50 40 30 20 10 0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5

Direct Compression Melt Granulation Wet Granulation Control

Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added

Lutrol 127 micro 1:3 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 127 1:3 Ratio


120

100

% Drug Release

80

60

Direct Compression
40

Melt Granulation
20

Wet Granulation Control

0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5

Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added

Lutrol 127 micro 1:5 ratio

Helping make Pharmaceuticals betterTM

Carbamazepine and Lutrol 127 1:5 Ratio


120

100

% Drug Release

80

60

40

Direct Compression Wet Granulation

20

Melt Granulation Control

0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5

Time (Hrs)
n n n n

Actives

Excipients

Contract Manufacturing

Value Added

Lutrol 127 micro Dissolution

Helping make Pharmaceuticals betterTM

Comparing 1:5 and 1:3 ratio Lutrol 127 direct compression tablet
90 80 70

% Drug Release

60 50 40 30 20 10 0 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5

1:5 Ratio Lutrol 127 1:3 Ratio Lutrol 127

Time (Hrs)
n Actives n Excipients n Contract Manufacturing n Value Added

Conclusions

Helping make Pharmaceuticals betterTM

Use of poloxamers, regardless of granulation technique, improved the solubility of Carbamazepine. Higher levels of poloxamer create a greater binding effect, which has an impact on dissolution. Microprilled Poloxamers exhibit good blend homogeneity and eliminate the segregation problem during direct compression. The gelling characteristic of microprilled Poloxamer 407 can be used for controlled release or other drug delivery technology. Microprill poloxamer can be a good candidate as a water soluble lubricant for effervescent tablets.

Actives

Excipients

Contract Manufacturing

Value Added

Helping make Pharmaceuticals betterTM

ARE THERE ANY QUESTIONS ????


n Actives n Excipients n Contract Manufacturing n Value Added

Ibuprofen Formulations Process

Helping make Pharmaceuticals betterTM

Dissolution studies with capsules and tablets were evaluated Tablets compressed using 11mm round flat face bevel edge tooling Target weight 800mg, target hardness 4-5Kp Using Ibuprofen as a model drug dissolution studies were carried out at pH 4.5 (where Ibuprofen has limited solubility)

CRS 2005/ 32nd Symposium on Controlled Release of Bioactive Materials / 18.-22.06.2005 / Miami, Florida, U.S.A.

Actives

Excipients

Contract Manufacturing

Value Added

You might also like